Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.

AIDS (London, England) - 1 Dec 2000

Guérin S, Meyer L, Theodorou I, Boufassa F, Magierowska M, Goujard C, Rouzioux C, Debré P, Delfraissy J F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Follow-Up Studies
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Odds Ratio

Share to Receptors, CCR5

Share to Sequence Deletion

Source

Identifiers

PMID: 11125899
DOI: 10.1097/00002030-200012010-00020

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients.PMID 11125899Read ↗

CCR5Δ32 mutation and HIV infection: basis for curative HIV therapySemantic proximity Read ↗

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?Semantic proximity Read ↗

HIV and the CCR5-Delta32 resistance allele.Semantic proximity Read ↗

Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression.Semantic proximity Read ↗

Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.Semantic proximity Read ↗

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Semantic proximity Read ↗

New Knowledge About CCR5, HIV Infection, and Disease Progression: Is "Old" Still Valuable?Semantic proximity Read ↗

Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.Semantic proximity Read ↗

The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progressionSemantic proximity Read ↗

An HIV-1-infected individual homozygous for the CCR-5 delta32 allele and the SDF-1 3'A allele.Semantic proximity Read ↗

CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.Semantic proximity Read ↗

The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.